The two groups were compared for variables of age, gender, tumor location, histology, depth of tumor invasion, lymph node metastasis, lymph invasion, venous invasion, distant metastasis, CEA level, and KRAS, NRAS, and HRAS mutations. The gene discussed is HRAS; the disease is neoplasm.